0000899243-20-027918.txt : 20201009 0000899243-20-027918.hdr.sgml : 20201009 20201009172358 ACCESSION NUMBER: 0000899243-20-027918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201007 FILED AS OF DATE: 20201009 DATE AS OF CHANGE: 20201009 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valle Franco CENTRAL INDEX KEY: 0001699848 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38533 FILM NUMBER: 201233989 MAIL ADDRESS: STREET 1: 999 SKYWAY ROAD, SUITE 150 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eidos Therapeutics, Inc. CENTRAL INDEX KEY: 0001731831 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463733671 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-391-9740 MAIL ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-07 0 0001731831 Eidos Therapeutics, Inc. EIDX 0001699848 Valle Franco C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2000 SAN FRANCISCO CA 94104 0 1 0 0 Senior Vice President, Finance Common Stock 2020-10-07 4 M 0 5000 7.24 A 5444 D Common Stock 2020-10-07 4 S 0 5444 75.0823 D 0 D Common Stock 2020-10-08 4 M 0 5199 7.24 A 5199 D Common Stock 2020-10-08 4 S 0 5199 74.8511 D 0 D Stock Option (Right to Buy) 7.24 2020-10-07 4 M 0 5000 0.00 D 2028-05-06 Common Stock 5000 34419 D Stock Option (Right to Buy) 7.24 2020-10-08 4 M 0 5199 0.00 D 2028-05-06 Common Stock 5199 29220 D Represents the weighted average sale price of the shares sold from $74.9701 to $75.3901 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2. Represents the weighted average sale price of the shares sold from $74.77 to $74.95 per share. The option, originally representing a right to purchase a total of 77,919 shares, vested and became exercisable as to 25% of the original option on March 28, 2019, and the remainder vests in 36 additional monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer. /s/ Franco Valle 2020-10-09